Open Save New
FeedNavigator / National Library of Health Sciences
 
  
Tutkijat / Institutions
AddAarnio, M(arkku) (KSSHP)
AddAlafuzoff, I. (Uppsala)
AddAro, A. (THL)
AddAromaa, A. (THL)
AddArvas, M(ikko) (Veripalvelu)
AddBamford, D.H. (UH Viikki Campus)
AddButcher, S. (UH Viikki Campus)
AddCerullo, V. (UH Viikki Campus)
AddEkblom-Kullberg, S(usanne) (Veripalvelu)
AddEskola, J. (THL)
AddFinel, M(oshe) (UH Viikki Campus)
AddGahmberg, C.G. (UH Viikki Campus)
AddHaimila, K(atri) (Veripalvelu)
AddHäkkinen, U. (THL)
AddHanski, I(lkka) (1953-2016) (UH Viikki Campus)
AddHari, R. (Aalto)
AddHavulinna, A(ki) S. (THL)
AddHemminki, E. (THL)
AddHiltunen, L(eena) (Veripalvelu)
AddHiltunen, R(aimo) (UH Viikki Campus)
AddHolthöfer, H. (CBAS, Dublin)
AddHovi, T. (THL)
AddHuoponen, O(uti) (Veripalvelu)
AddHuovinen, P. (THL)
AddHyytiä, P. (THL)
AddImpola, U(lla) (Veripalvelu)
AddJaatinen, T(aina) (Veripalvelu)
AddJacobs, H.T. (UH Viikki Campus)
AddJalanko, A. (THL)
AddJalkanen, J(yrki) (KSSHP)
AddJantunen, M. (THL)
AddJavela, K(aija) (Veripalvelu)
AddJoensuu, T(imo) (Docrates Cancer Center)
AddJokela, J(orma) (Laurea)
AddJokitalo, E. (UH Viikki Campus)
AddJousilahti, P(ekka) (THL)
AddJulkunen, I. (THL)
AddJuppo, A(nne) (UH Viikki Campus)
AddKääriäinen, H. (THL)
AddKaartinen, T(anja) (Veripalvelu)
AddKairemo, K(alevi) (Docrates)
AddKallioniemi, O(lli) (SciLifeLab)
AddKarvonen, M. (THL)
AddKayhty, H. (THL)
AddKerkelä, E(rja) (Veripalvelu)
AddKeskimäki, I. (THL)
AddKiianmaa, K. (THL)
AddKinnunen, P.K. (Aalto)
AddKirjavainen, V(esa) (Veripalvelu)
AddKlaukka, T. (Kela)
AddKorhonen, M(atti) (Veripalvelu)
AddKoskela, S(atu) (Veripalvelu)
AddKoskinen, S(eppo) (THL)
AddKovanen, P.T. (Wihuri)
AddKyrölä, K(ati) (KSSHP)
AddLaatikainen, T(iina) (THL)
AddLähteenmäki, K(aarina) (Veripalvelu)
AddLaitinen, S(aara) (Veripalvelu)
AddLappalainen, P. (UH Viikki Campus)
AddLarjo, A(ntti) (Veripalvelu)
AddLauronen, J(ouni) (Veripalvelu)
AddLehtinen, M(atti) (THL)
AddLeino-Arjas, P. (TTL)
AddLeinonen, M. (THL)
AddLindros, K. (THL)
AddLinjama, T(iina) (Veripalvelu)
AddLönnqvist, J. (THL)
AddMäkelä, M. (THL)
AddMäkelä, P.H. (THL)
AddMalmivaara, A(ntti) (THL)
AddMännistö, P. (UH Viikki Campus)
AddMattila, P. (PSHP)
AddMattila, P(irkko) (Veripalvelu/FIMM)
AddMättö, J(aana) (Veripalvelu)
AddNatunen, S(uvi) (Veripalvelu)
AddNissinen, A. (THL)
AddNystedt, J(ohanna) (Veripalvelu)
AddOvaskainen. M.L (THL).
AddPalosuo, T. (THL)
AddPalva, A(iri) (UH Viikki Campus)
AddPartanen, J(ukka) (Veripalvelu)
AddPartonen, T. (THL)
AddPatja, K. (THL)
AddPeltonen, M(arkku) (THL)
AddPeräsaari, J(uha) (Veripalvelu)
AddPietinen, P. (THL)
AddPrattala, R. (THL)
AddPuska, P. (THL)
AddQiao, Q(ing) (THL)
AddReunanen, A. (THL)
AddRiihimäki, H. (TTL)
AddRitari, J(armo) (Veripalvelu)
AddRuotsalainen, P. (THL)
AddRuskoaho, H(eikki) (UH Viikki Campus)
AddRuutu, P. (THL)
AddSaarma, M. (UH Viikki Campus)
AddSaarni, S.I. (THL)
AddSaikku, P. (THL)
AddSainio, S(usanna) (Veripalvelu)
AddSalomaa, V(eikko) (THL)
AddShimmi, O. (UH Viikki Campus)
AddSiitonen, A. (THL)
AddSolantaus, T. (THL)
AddThesleff, I. (UH Viikki Campus)
AddTuomisto, J. (THL)
AddUutela, A. (THL)
AddVaarala, O. (THL)
AddValsta, L. (THL)
AddVartiainen, E(rkki) (THL)
AddVartiainen, T. (THL)
AddVasankari, T(ommi) (UKK)
AddViikari-Juntura, E. (TTL)
AddVirtamo, J. (THL)
AddVirtanen, S.M. (THL)
AddVuopio, J. (THL)
AddWahlbeck, K. (THL)
AddWikström, M. (UH Viikki Campus)

Scholar Chart >>



»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Oncolytic Adenoviruses for Cancer TherapyCerullo, V. (UH Viikki Campus)14 dayssaveRefWorksSFX Info
GAMER-Ad: a novel and rapid method for generating recombinant adenovirusesCerullo, V. (UH Viikki Campus)33 dayssaveRefWorksSFX Info
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platformCerullo, V. (UH Viikki Campus)33 dayssaveRefWorksSFX Info
Patient-derived organoids for precision cancer immunotherapyCerullo, V. (UH Viikki Campus)38 dayssaveRefWorksSFX Info
Viral Nanoparticles: Cancer Vaccines and Immune ModulatorsCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Pathogens: Our Allies against Cancer?Cerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous MelanomaCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Influence of Cell Membrane Wrapping on the Cell-Porous Silicon Nanoparticle InteractionsCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Uncovering the Tumor Antigen Landscape: What to Know about the Discovery ProcessCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfacesCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA deliveryCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer ImmunotherapyCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarctionCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Design and application of oncolytic viruses for cancer immunotherapyCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Artificially cloaked viral nanovaccine for cancer immunotherapyCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanomaCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapyCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor siteCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint InhibitorCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasksCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient miceCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer TherapyCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent miceCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumorsCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped VirusesCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatmentCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse modelCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
A novel <em>in silico</em> framework to improve MHC-I epitopes and break the tolerance to melanomaCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesiclesCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 - Support for clinical studies on advanced cancer treatmentCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Beyond Gene Delivery: Strategies to Engineer the Surfaces of Viral VectorsCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune SystemCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunityCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytesCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma modelCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanomaCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapyCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapyCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor ActivityCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic AdenovirusCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humansCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Immunological effects of a tumor necrosis factor alpha-armed oncolytic adenovirusCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumorsCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
GMCSF-armed vaccinia virus induces an antitumor immune responseCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcomaCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
The evolution of adenoviral vectors through genetic and chemical surface modificationsCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humansCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imagingCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus respondersCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatmentCerullo, V. (UH Viikki Campus)41 dayssaveRefWorksSFX Info
 XML / RSS feed
report
next »